Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase NA 1

Status

Completed 186Terminated 37Unknown 18Withdrawn 15Recruiting 12Active not recruiting 6Not yet recruiting 1

Sponsor Class

OTHER 299INDUSTRY 129NIH 49OTHER_GOV 11NETWORK 6FED 1

Study Type

Interventional 4Observational 2

Sponsor

Cancer Type

Breast 30Genitourinary 27Other hematologic neoplasm 26Lymphoid 25CNS 19Plasma cell 16Thoracic 15Gastrointestinal 14Head & Neck 7Sarcoma 6Myeloid 6Gynecologic 6Tumor-Agnostic 5Dermatologic 3Other neoplasm 2Endocrine 2Other solid neoplasm 1

Conditions

Endometrial Neoplasms 2Uterine Cervical Dysplasia 1Papillomavirus Infections 1Ovarian Neoplasms 1Ovarian Cancer Prevention 1Lung Neoplasms 1Gynecologic Cancer 1Endometrial Hyperplasia 1Carcinoma, Non-Small-Cell Lung 1

Interventions

abemaciclib 1Paclitaxel 1Observation 1Letrozole 1Drug Therapy 1Carboplatin 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Active not recruiting × NETWORK × Gynecologic × Clear all
NCT03515993 2026-05-12

Follow-up in Gynecological Cancer Survivors

European Organisation for Research and Treatment of Cancer - EORTC

Active not recruiting
1,100 enrolled
Gynecologic

Gynecologic Cancer

NCT01244789 2026-04-13

Chemotherapy or Observation in Stage I-II Intermediate or High Risk Endometrial Cancer

Danish Gynecological Cancer Group

Phase 2 Active not recruiting
244 enrolled
Gynecologic

Endometrial Neoplasms

NCT03939481 2026-04-13

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

SWOG Cancer Research Network

Active not recruiting
1,336 enrolled
GynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Ovarian Neoplasms

NCT04393285 2026-03-09

Abemaciclib and Letrozole to Treat Endometrial Cancer

GOG Foundation

Phase 2 Active not recruiting
53 enrolled
Gynecologic

Endometrial Neoplasms

NCT03480776 2026-01-14

ASA in Prevention of Ovarian Cancer (STICs and STONEs)

Canadian Cancer Trials Group

Phase 2 Active not recruiting
117 enrolled
Gynecologic

Ovarian Cancer Prevention

NCT00892866 2024-05-03

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing Cervical Lesions in Patients With Abnormal Cervical Cells

GOG Foundation

Phase NA Active not recruiting
877 enrolled
Gynecologic

Uterine Cervical Dysplasia, Endometrial Hyperplasia, Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡